Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Hepatology (Baltimore, Md.)|March 19, 2013
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinomaMassimiliano Cadamuro, Giorgia Nardo, Stefano Indraccolo, et al.Annals of Surgical Oncology|September 10, 2025
CT-Based Radiomics Models with External Validation for Prediction of Recurrence and Disease-Specific Mortality After Radical Surgery of Colorectal Liver MetastasesSimona Marzi, Antonello Vidiri, Anna Ianiro, et al.Journal of Hepatology|December 17, 2018
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinomaMassimiliano Cadamuro, Simone Brivio, Joachim Mertens, et al.International Journal of Surgery (London, England)|April 24, 2023
IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients - a cohort studyGaya Spolverato, Matteo Fassan, Giulia Capelli, et al.The British Journal of Surgery|July 21, 2023
IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancerGaya Spolverato, Matteo Fassan, Melania Scarpa, et al.Cancer|April 22, 2024
IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancerOttavia De Simoni, Melania Scarpa, Ignazio Castagliuolo, et al.Scientific Reports|November 30, 2024
IMMUNOREACT 9 metachronous rectal cancers have high HLA-ABC expression on healthy epithelium but a lower infiltration of CD3+ T cells than primary lesionsBeatrice Salmaso, Melania Scarpa, Valerio Pellegrini, et al.Surgery|November 21, 2024
IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancerGiulia Becherucci, Cesare Ruffolo, Melania Scarpa, et al.Cancers|February 27, 2026
IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal CancerOttavia De Simoni, Melania Scarpa, Francesco Cavallin, et al.Cancers|June 26, 2026
Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?-The IMMUNOREACT 20 StudyLorenzo Dell'Atti, Andromachi Kotsafti, Francesca Galuppini, et al.Pageof 2